Investor's Business Daily on MSN1h
How A Side Effect Has Wiped Out Nearly 73% Of Neurogene's Value In A WeekNeurogene stock collapsed, again, on Monday after the company scrapped the high dose of its experimental Rett Syndrome ...
Leerink Partners, the health-care advisory firm, has continued a recent recruitment drive with hires from boutiques ...
CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling ...
Research analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of Ardent Health Partners in a ...
Equities researchers at Leerink Partnrs decreased their FY2024 earnings per share (EPS) estimates for Vincerx Pharma in a ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Industry Veterans Grant Curry and Jason Truman Join Leerink Partners. BOSTON, Nov. 14, 2024 /PRNewswire/ -- Leerink Partners, a leading investment bank specializing in healthcare, announced today ...
Bristol-Myers Squibb (BMY) stock was upgraded by Leerink Partners based on a potential sales boost for its schizophrenia ...
Leerink Partners analyst Mani Foroohar maintained a Hold rating on CureVac (CVAC – Research Report) on November 12. The company’s ...
Leerink Partners and Cantor acted as placement agents in connection with the private placement. Don't Miss our Black Friday Offers: Published first on TheFly – the ultimate source for real-time, ...
Robert F. Kennedy Jr.'s nomination to lead HHS is causing cautious concern among investors. Here's which companies and stocks ...
On Friday, Geron Corp (GERN) stock saw a decline, ending the day at $3.66 which represents a decrease of $-0.05 or -1.35% from the prior close of $3.71. The stock opened at $3.73 and touched a low of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback